Polypharmacy, potentially serious clinically relevant drug‐drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life
Author:
Affiliation:
1. Faculty of Pharmacy University of Lisbon Lisbon Portugal
2. Centre for Health Evaluation & Research (CEFAR) Lisbon Portugal
3. Nova Medical School Nova University of Lisbon Lisbon Portugal
4. Portuguese Diabetes Association (APDP) Lisbon Portugal
Funder
Portuguese National Association of Pharmacies
Publisher
Wiley
Subject
General Pharmacology, Toxicology and Pharmaceutics,Neurology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.621
Reference45 articles.
1. Global prevalence of Type 2 diabetes over the next ten years (2018–2028);Kaiser AB;Diabetes,2018
2. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: A prospective population-based study in The Netherlands (ZODIAC-1)
3. Standards of medical care in diabetes—2019;Adults O;Diabetes Care,2019
4. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
5. Antidiabetic Medications and Polypharmacy
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Drug–drug interactions and the risk of adverse drug reaction‐related hospital admissions in the older population;British Journal of Clinical Pharmacology;2023-12-26
2. Control Level of Type 2 Diabetes Mellitus in the Elderly Is Associated with Polypharmacy, Accompanied Comorbidities, and Various Increased Risks According to the Beers Criteria;Diagnostics;2023-11-13
3. Potentially inappropriate medication and frailty in older adults: A systematic review and meta-analysis;Archives of Gerontology and Geriatrics;2023-11
4. Association between depression and quality of life in older adults with type 2 diabetes: A moderated mediation of cognitive impairment and sleep quality;Journal of Affective Disorders;2023-11
5. An age-stratified cross-sectional study of antidiabetic and non-antidiabetic drugs prescribed to Japanese outpatients with diabetes;Global Health & Medicine;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3